AFAP1 and cancer: In murine models of breast, colon and lung cancers, and in human xenograft models of lung, colon, PDAC and OSCC cancers, PT-630, a small molecule inhibiting the peptidyl peptidase activity of αFAP, and anti-αFAP monoclonal antibodies have been used.